F-STAR THERAPEUTICS, INC. Proceeds from Stock Options Exercised
F-STAR THERAPEUTICS, INC. reported Proceeds from Stock Options Exercised of $92.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2019-03-11
- F-STAR THERAPEUTICS, INC. proceeds from stock options exercised for the quarter ending 2017-12-31 was $0.00.
- F-STAR THERAPEUTICS, INC. proceeds from stock options exercised for the quarter ending 2017-09-30 was $0.00.
- F-STAR THERAPEUTICS, INC. proceeds from stock options exercised for the quarter ending 2017-06-30 was $90.00K.
- F-STAR THERAPEUTICS, INC. proceeds from stock options exercised for the quarter ending 2017-03-31 was $2.00K.
- F-STAR THERAPEUTICS, INC. proceeds from stock options exercised for fiscal 2017 was $92.00K, a 3.16% decline from fiscal 2016.
- F-STAR THERAPEUTICS, INC. proceeds from stock options exercised for fiscal 2016 was $95.00K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11 | $0.00 derived: sum of 2 quarters · filed 2019-03-11 | $90.00K derived: sum of 3 quarters · filed 2019-03-11 | $92.00K 10-K · filed 2019-03-11 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | $90.00K derived: sum of 2 quarters · filed 2018-10-25 | $92.00K 10-Q · filed 2018-10-25 | $92.00K derived: sum of 4 quarters · filed 2018-10-25 |
| 2017-06-30 | $90.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $92.00K 10-Q · filed 2018-08-02 | $92.00K derived: sum of 3 quarters · filed 2018-08-02 | |
| 2017-03-31 | $2.00K 10-Q · filed 2018-04-27 | $2.00K derived: sum of 2 quarters · filed 2018-04-27 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-20 | $95.00K 10-K · filed 2018-02-20 | ||
| 2016-09-30 | $95.00K 10-Q · filed 2017-10-31 |